Immune-Onc Therapeutics logo

Immune-Onc Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States11-50 Employees

Immune-Onc Therapeutics is a private biotechnology company headquartered in Palo Alto, California, focused on discovering and developing therapies that target inhibitory receptors on myeloid cells. Its pipeline concentrates on the Leukocyte Immunoglobulin-Like Receptor B (LILRB) family, pursuing an approach aimed at modulating the immune environment to treat cancer. The company has several lead assets in clinical development, including IO-108, which targets LILRB2, and IO-202, which targets LILRB4, along with additional programs in the works.

Immune-Onc operates in oncology and immunotherapy, with the goal of addressing tumor-associated myeloid cell inhibition to enhance anti-tumor responses. It advances through early clinical development, with IO-202 in Phase 1b for AML, CMML, and solid tumors, and IO-108 in Phase 1b/2 for solid tumors. In 2024, Immune-Onc announced an oral presentation at the American Society of Hematology Annual Meeting to share data from the IO-202 Phase 1b study in CMML.

Find Immune-Onc Therapeutics employees' phone numbers or email addresses

Immune-Onc Therapeutics Global Highlights

Location
Employees

North America
14

Minus sign iconPlus sign icon
  • United States Of America
    14

Asia
5

Minus sign iconPlus sign icon
  • China
    3
  • Pakistan
    1
  • India
    1

Immune-Onc Therapeutics's Leadership

  • Head Of Clinical Research at Immune-Onc Therapeutics
    W. H.
    Head Of Clinical Research
  • Director Of Human Resources And Operations at Immune-Onc Therapeutics
    S. Y.
    Director Of Human Resources And Operations
  • China General Manager at Immune-Onc Therapeutics
    M. G.
    China General Manager
  • Human Resources Manager at Immune-Onc Therapeutics
    A. S.
    Human Resources Manager
  • Senior Clinical Trial Manager at Immune-Onc Therapeutics
    S. W.
    Senior Clinical Trial Manager
  • Chairperson Of The Board at Immune-Onc Therapeutics
    C. L.
    Chairperson Of The Board
  • Shareholder / Supervisor at Immune-Onc Therapeutics
    D. S.
    Shareholder / Supervisor
  • Officer at Immune-Onc Therapeutics
    J. H.
    Officer

Immune-Onc Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Engineering
  • Operations
  • Program & Project Management
  • Research
  • Administrative
  • Other
  • Consultant
  • Human Resources
  • Entrepreneurship
  • Business
  • Sales
  • Biotechnology

Contact profiles from Immune-Onc Therapeutics

Name
Title
Contact
Location
Last Update
  • Head Of Clinical Research at Immune-Onc Therapeutics
    W. H.
    Head Of Clinical Research
    China, Shanghai
    May 22, 2026
  • Director Of Human Resources And Operations at Immune-Onc Therapeutics
    S. Y.
    Director Of Human Resources And Operations
    China, Shanghai
    Aug 30, 2026
  • China General Manager at Immune-Onc Therapeutics
    M. G.
    China General Manager
    China, Shanghai
    Jul 18, 2026
  • Human Resources Manager at Immune-Onc Therapeutics
    A. S.
    Human Resources Manager
    Oct 18, 2024
  • Senior Clinical Trial Manager at Immune-Onc Therapeutics
    S. W.
    Senior Clinical Trial Manager
    Oct 21, 2024
  • Chairperson Of The Board at Immune-Onc Therapeutics
    C. L.
    Chairperson Of The Board
    Bay
    Sep 05, 2026
  • Shareholder / Supervisor at Immune-Onc Therapeutics
    D. S.
    Shareholder / Supervisor
    India, Telangana
    May 03, 2023
  • Officer at Immune-Onc Therapeutics
    J. H.
    Officer
    Oct 23, 2024

Frequently Asked Questions

What is Immune-Onc Therapeutics known for?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics was founded in 2016 and operates in the Biotechnology Research industry. You can contact Immune-Onc Therapeutics's main corporate office by phone at . Explore Immune-Onc Therapeutics's company overview page for more information.

What is Immune-Onc Therapeutics's most common email format?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics employees' email format typically follows the pattern of First.L@immune-onc.com. Trying to find reliable and up-to-date employee contact data? Find more Immune-Onc Therapeutics email formats with LeadIQ.

How many employees does Immune-Onc Therapeutics have currently?

Minus sign iconPlus sign icon
Immune-Onc Therapeutics has approximately 12 employees as of August 2026. These team members are located across 2 continents, including North America and Asia.

Who are Immune-Onc Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Immune-Onc Therapeutics's key employees include:

  • Head Of Clinical Research: W. H.
  • Director Of Human Resources And Operations: S. Y.
  • China General Manager: M. G.
  • Human Resources Manager: A. S.
  • Senior Clinical Trial Manager: S. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.